// App-Quantinova.ai

1111 : Severe Acquired Bleeding Tendency Secondary To An Anti-Thrombin Antibody In a Patient With Monoclonal Gammapathy Of Unknown Significance: Direct In Vivo evidence

Researchers

Presenter

  • Valerie Proulle

Principal Investigators

  • Celine Desconclois

  • Cecile Lavenu-Bombled

  • Cecile Goujard

  • Anish V Sharda

  • Ali G Turhan

Medical Centers

  • Paris Sud University Hospitals Bicetre & Paul Brousse, Le Kremlin Bicetre, France

  • AP-HP, Hopital Bicetre, Service de Medecine Interne, Kremlin Bicetre, France

  • AP-HP, Hopital Bicetre, Service Hematologie Biologique, Kremlin Bicetre, France

  • Universite Paris-Sud, Le Kremlin Bictre, France

  • Medicine - Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Venous thrombosis

  • Hematoma

  • Lupus

  • Monoclonal gammopathy

Biomarkers

  • Catalase

  • Immunoglobulin G

  • Activated partial thromboplastin time

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • Bortezomib

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved